HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CDAN1
codanin 1
Chromosome 15 Β· 15q15.2
NCBI Gene: 146059Ensembl: ENSG00000140326.14HGNC: HGNC:1713UniProt: Q8IWY9
39PubMed Papers
21Diseases
0Drugs
63Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
chromatin organizationintracellular protein localizationprotein bindingimport into nucleusCongenital dyserythropoietic anemia type Icongenital dyserythropoietic anemia type 1aortic valve diseaseaortic stenosis
✦AI Summary

CDAN1 (codanin 1) is an essential ubiquitous protein whose mutations cause congenital dyserythropoietic anemia type 1 (CDA1), a rare autosomal recessive disorder affecting erythroid development 1. The primary function of CDAN1 involves regulating histone chaperone activity through direct interaction with ASF1A and ASF1B proteins 1. Structurally, CDAN1 dimerizes and assembles into cytosolic complexes where it sequesters ASF1 molecules by occupying all functional binding sites required for histone chaperoning, thereby acting as a negative regulator of histone H3-H4 deposition during chr15 assembly 1. CDAN1 also interacts with CDIN1 and participates in a protein complex whose nuclear import is mediated by importin 4 (IPO4) 2. Functionally, CDAN1 is critical for primitive erythropoiesis, with genetic and animal models demonstrating its essential role in normal red blood cell development 3. CDA1 mutations result in ineffective erythropoiesis characterized by morphologically abnormal erythroblasts in bone marrow 4. The disease represents a key model for understanding erythroid differentiation-proliferation pathways and chr15 organization mechanisms in hematopoiesis 5. Next-generation sequencing has enabled molecular diagnosis and improved understanding of CDAN1-related pathogenesis 4.

Sources cited
1
CDAN1 dimerizes and sequesters ASF1A/B by occupying functional binding sites for histone chaperoning
PMID: 40091041
2
CDAN1 participates in nuclear protein complex with importin 4-mediated import and interacts with MMS22L
PMID: 41446536
3
CDAN1 is essential for primitive erythropoiesis as demonstrated in mouse models
PMID: 35441598
4
CDAN1 mutations cause CDA1 with characteristic morphological erythroblast abnormalities
PMID: 21378561
5
CDA1 is a form of ineffective erythropoiesis affecting erythroid differentiation-proliferation pathways
PMID: 32702750
Disease Associationsβ“˜21
Congenital dyserythropoietic anemia type IOpen Targets
0.83Strong
congenital dyserythropoietic anemia type 1Open Targets
0.64Moderate
aortic valve diseaseOpen Targets
0.32Weak
aortic stenosisOpen Targets
0.28Weak
genetic disorderOpen Targets
0.19Weak
congenital dyserythropoietic anemiaOpen Targets
0.16Weak
heart valve diseaseOpen Targets
0.16Weak
tooth diseaseOpen Targets
0.08Suggestive
diabetes mellitusOpen Targets
0.07Suggestive
poisoningOpen Targets
0.05Suggestive
diabetic nephropathyOpen Targets
0.05Suggestive
46,XY complete gonadal dysgenesisOpen Targets
0.05Suggestive
Testicular regression syndromeOpen Targets
0.04Suggestive
hypogonadotropic hypogonadism 11 with or without anosmiaOpen Targets
0.04Suggestive
response to antibioticOpen Targets
0.04Suggestive
pemphigus foliaceusOpen Targets
0.04Suggestive
46,XX ovotesticular disorder of sex developmentOpen Targets
0.04Suggestive
thrombocytopenia with congenital dyserythropoietic anemiaOpen Targets
0.03Suggestive
tetragametic chimerismOpen Targets
0.03Suggestive
spermatogenic failure, X-linked, 2Open Targets
0.03Suggestive
Anemia, congenital dyserythropoietic, 1AUniProt
Pathogenic Variants63
NM_138477.4(CDAN1):c.156C>G (p.Phe52Leu)Pathogenic
not provided|Anemia, congenital dyserythropoietic, type 1a|Congenital dyserythropoietic anemia, type I|CDAN1-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 52
NM_138477.2(CDAN1):c.2015C>T (p.Pro672Leu)Pathogenic
Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a
β˜…β˜…β˜†β˜†2026β†’ Residue 672
NM_138477.4(CDAN1):c.3124C>T (p.Arg1042Trp)Pathogenic
Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1042
NM_138477.4(CDAN1):c.1596dup (p.Met533fs)Pathogenic
Anemia, congenital dyserythropoietic, type 1a|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 533
NM_138477.4(CDAN1):c.1791_1792delinsTCTTGCCCTGGCTTGAAGA (p.Glu597_Leu598delinsAspLeuAlaLeuAlaTer)Pathogenic
Anemia, congenital dyserythropoietic, type 1a|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 597
NM_138477.4(CDAN1):c.2044C>T (p.Arg682Ter)Pathogenic
Anemia, congenital dyserythropoietic, type 1a|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 682
NM_138477.4(CDAN1):c.3024_3025insTT (p.Glu1009fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 1009
NM_138477.4(CDAN1):c.3389C>T (p.Pro1130Leu)Pathogenic
Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a
β˜…β˜…β˜†β˜†2024β†’ Residue 1130
NM_138477.4(CDAN1):c.2140C>T (p.Arg714Trp)Pathogenic
Congenital dyserythropoietic anemia, type I|not provided|Anemia, congenital dyserythropoietic, type 1a
β˜…β˜…β˜†β˜†2024β†’ Residue 714
NM_138477.4(CDAN1):c.1796A>G (p.Asn599Ser)Likely pathogenic
Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a
β˜…β˜…β˜†β˜†2024β†’ Residue 599
NM_138477.4(CDAN1):c.152C>T (p.Pro51Leu)Likely pathogenic
Congenital dyserythropoietic anemia, type I|Anemia, congenital dyserythropoietic, type 1a
β˜…β˜…β˜†β˜†2024β†’ Residue 51
NM_138477.4(CDAN1):c.2852_2853del (p.Glu951fs)Pathogenic
Anemia, congenital dyserythropoietic, type 1a|not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 951
NM_138477.4(CDAN1):c.2645+2T>CLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2026
NC_000015.10:g.42730757_42730765delPathogenic
not provided
β˜…β˜†β˜†β˜†2026
NM_138477.4(CDAN1):c.3175C>T (p.Gln1059Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1059
NM_138477.4(CDAN1):c.412del (p.Glu138fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 138
NM_138477.4(CDAN1):c.1793_1794insTGCCCTGGCTTGAAGAT (p.Leu598_Asn599insAlaLeuAlaTer)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 598
NM_138477.4(CDAN1):c.3096del (p.Asp1033fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 1033
NM_138477.4(CDAN1):c.699_702dup (p.Pro235Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 235
NM_138477.4(CDAN1):c.2681_2682del (p.Glu894fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 894
View on ClinVar β†—
Related Genes
ASF1AProtein interaction90%ASF1BProtein interaction90%IPO4Protein interaction90%STRCProtein interaction81%CATSPER2Protein interaction80%AARS2Protein interaction78%
Tissue Expression6 tissues
Bone Marrow
100%
Ovary
94%
Liver
41%
Lung
32%
Heart
24%
Brain
14%
Gene Interaction Network
Click a node to explore
CDAN1ASF1AASF1BIPO4STRCCATSPER2AARS2
PROTEIN STRUCTURE
Preparing viewer…
PDB9CVC Β· 3.50 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.91LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.77 [0.66–0.91]
RankingsWhere CDAN1 stands among ~20K protein-coding genes
  • #10,290of 20,598
    Most Researched39
  • #1,135of 5,498
    Most Pathogenic Variants63 Β· top quartile
  • #8,261of 17,882
    Most Constrained (LOEUF)0.91
Genes detectedCDAN1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Congenital dyserythropoietic anemias.
PMID: 32702750
Blood Β· 2020
1.00
2
Mechanism of ASF1 engagement by CDAN1.
PMID: 40091041
Nat Commun Β· 2025
0.90
3
Congenital dyserythropoietic anemias.
PMID: 21378561
Curr Opin Hematol Β· 2011
0.80
4
Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran Program.
PMID: 36802703
Circulation Β· 2023
0.70
5
Congenital dyserythropoietic anemia.
PMID: 20820969
Int J Hematol Β· 2010
0.60